{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2001-N-0178\" sorted by posted_date descending", "rows": [["FDA-2001-N-0178-0053", "FDA", "FDA-2001-N-0178", "Performance Standard for Diagnostic X-Ray Systems and Their Major Components (21CFR 1020.30, 1020.31, 1020.32,\n1020.33); Small Entity Compliance Guide; Guidance for Industry and Food and Drug Administration Staff", "Other", "Guidance", "2023-02-22T05:00:00Z", 2023, 2, "2023-02-22T05:00:00Z", null, "2024-11-07T00:47:49Z", null, 1, 0, "09000064856e13af"], ["FDA-2001-N-0178-0052", "FDA", "FDA-2001-N-0178", "Performance Standard for Diagnostic X-Ray Systems and Their Major Components (21CFR 1020.30, 1020.31, 1020.32, 1020.33); Small Entity Compliance Guide", "Other", "Guidance", "2023-02-22T05:00:00Z", 2023, 2, "2023-02-22T05:00:00Z", null, "2023-02-22T14:25:08Z", null, 0, 0, "09000064845683d4"], ["FDA-2001-N-0178-0041", "FDA", "FDA-2001-N-0178", "Attachment 1 Gofman 2002 What Are the Main Critiques of the 1999 Study re: Comment from John W. Gofman", "Supporting & Related Material", "Background Material", "2016-02-03T05:00:00Z", 2016, 2, null, null, "2016-02-03T15:03:20Z", null, 0, 0, "0900006481e4a4f9"], ["FDA-2001-N-0178-0043", "FDA", "FDA-2001-N-0178", "Attachment 3 Gofman 1999, Executive Summary re: Comment from John W. Gofman", "Supporting & Related Material", "Background Material", "2016-02-03T05:00:00Z", 2016, 2, null, null, "2016-02-03T15:07:54Z", null, 0, 0, "0900006481e4a4fb"], ["FDA-2001-N-0178-0042", "FDA", "FDA-2001-N-0178", "Attachment 2 Critique by Arthur C. Upton re: Comment from John W. Gofman", "Supporting & Related Material", "Background Material", "2016-02-03T05:00:00Z", 2016, 2, null, null, "2016-02-03T15:05:26Z", null, 0, 0, "0900006481e4a4fa"], ["FDA-2001-N-0178-0011", "FDA", "FDA-2001-N-0178", "Reference 2 FDA Guidance Document Guidance for the Submission of 510(k)'s for Solid State X-ray Imaging Devices re:  Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T14:55:55Z", null, 0, 0, "0900006481e42afa"], ["FDA-2001-N-0178-0024", "FDA", "FDA-2001-N-0178", "Reference 25 Gkanatsios, et al evaluation of an On-Line Patient Exposure Meter in Neuroradiology re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:13:34Z", null, 0, 0, "09000064804e15af"], ["FDA-2001-N-0178-0033", "FDA", "FDA-2001-N-0178", "Tab B Changes of Initial Draft (FRN) Submitted to OIRA for Review and Action re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:23:32Z", null, 0, 0, "09000064804e15df"], ["FDA-2001-N-0178-0015", "FDA", "FDA-2001-N-0178", "Reference 17 Council Directive 97/43 euration Health Protection of Individuals Against the Dangers of Ionizing Radiation in Relation to Medical Exposure re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T16:23:45Z", null, 0, 0, "0900006481e427ab"], ["FDA-2001-N-0178-0012", "FDA", "FDA-2001-N-0178", "Reference 9 FDA CDRH Handbook of Selected Tissue Doses for Fluoroscopic and Cineangiographic Examination of the Coronary Arteries re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T15:21:49Z", null, 0, 0, "0900006481e42af4"], ["FDA-2001-N-0178-0027", "FDA", "FDA-2001-N-0178", "Reference 29 Stern et al Estimated Benefits of Proposed Amendments to the FDA Radiation-Safety Standard for Diagnostic X-ray Equipment 2001 FDA Science Forum,\nWash, DC, February 15 thru 16, 2001 re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:16:26Z", null, 0, 0, "09000064804e15aa"], ["FDA-2001-N-0178-0025", "FDA", "FDA-2001-N-0178", "Reference 26 Geise, R. et al Radiation Doses during Pediatric Radiofrequency Catheter Ablation Procedures, PACE re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:14:04Z", null, 0, 0, "09000064804e15ad"], ["FDA-2001-N-0178-0028", "FDA", "FDA-2001-N-0178", "Reference 30 Committee on Interagency Radiation Research and Policy Coordination Science Use of BEIR V AND UNSCEAR 1988 in Radiation Risk Assessment, December 1992 re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:16:56Z", null, 0, 0, "09000064804e15c6"], ["FDA-2001-N-0178-0029", "FDA", "FDA-2001-N-0178", "Reference 31 Sources and Effects of Ionizing Radiation United Nations Scientific Committee on the Effects of Atomic Radiation re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:17:52Z", null, 0, 0, "09000064804e15c9"], ["FDA-2001-N-0178-0031", "FDA", "FDA-2001-N-0178", "Memorandum from OMB OIRA to FDA DDM", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:22:39Z", null, 0, 0, "09000064804e15e9"], ["FDA-2001-N-0178-0018", "FDA", "FDA-2001-N-0178", "Reference 20 FDA Recording Information in the Patient's Medical Record that Identifies the Potential for Serious X-ray Induced Skin Injuries Following Fluoroscopically Guided Procedures re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:01:06Z", null, 0, 0, "0900006481e427a8"], ["FDA-2001-N-0178-0020", "FDA", "FDA-2001-N-0178", "Reference 8 Proceedings of the ACR/FDA Workshop on Fluroscopy Strategies for Improvement in Performance, Radiation Safety and Control October 16 & 17, 1992 re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components Part 2 of 3", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:06:42Z", null, 0, 0, "09000064804e15d4"], ["FDA-2001-N-0178-0026", "FDA", "FDA-2001-N-0178", "Reference 27 Transcript of Proceedings Twenty-fifth Meeting of the Technical Electronic Product Radiation Safety Standards Committee September 1998 re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:14:40Z", null, 0, 0, "09000064804e15c4"], ["FDA-2001-N-0178-0017", "FDA", "FDA-2001-N-0178", "Reference 19 FDA Public Health Advisory: Avoidance of Serious x-ray Induced Skin Injuries to Patients during Fluoroscopically-Guided Procedures re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T16:53:47Z", null, 0, 0, "0900006481e427a9"], ["FDA-2001-N-0178-0021", "FDA", "FDA-2001-N-0178", "Reference 8 Proceedings of the ACR/FDA Workshop on Fluroscopy Strategies for Improvement in Performance, Radiation Safety and Control October 16 & 17, 1992 re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components Part 3 of 3", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:06:56Z", null, 0, 0, "09000064804e15dc"], ["FDA-2001-N-0178-0034", "FDA", "FDA-2001-N-0178", "Memorandum from OMB OIRA to FDA DDM", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:25:19Z", null, 0, 0, "09000064804e1639"], ["FDA-2001-N-0178-0019", "FDA", "FDA-2001-N-0178", "Reference 8 Proceedings of the ACR/FDA Workshop on Fluroscopy Strategies for Improvement in Performance, Radiation Safety and Control October 16 & 17, 1992 re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components Part 1 of 3", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:06:26Z", null, 0, 0, "09000064804e15d0"], ["FDA-2001-N-0178-0016", "FDA", "FDA-2001-N-0178", "Reference 18 FDA Avoidance of Serious X-ray Induced Skin Injuries to Patients during Fluoroscopically-Guided Procedures re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T16:35:41Z", null, 0, 0, "0900006481e427aa"], ["FDA-2001-N-0178-0013", "FDA", "FDA-2001-N-0178", "Reference 10 Rudin and Bednarek Spatial Shaping of the Beam: Collimation, Grids, Equalization Filters, and Region-of-Interest Fluoroscopy re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T15:27:20Z", null, 0, 0, "0900006481e42af3"], ["FDA-2001-N-0178-0014", "FDA", "FDA-2001-N-0178", "Reference 11 Solomon et al Low-exposure Scanning-beam X-ray Fluoroscopy System re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T15:31:58Z", null, 0, 0, "0900006481e42af2"], ["FDA-2001-N-0178-0023", "FDA", "FDA-2001-N-0178", "Reference 23 Bauml, et al Joint WHO/ISH Workshop on Efficacy and Radiation safety in Interventional Radiology re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:12:27Z", null, 0, 0, "09000064804e15b2"], ["FDA-2001-N-0178-0036", "FDA", "FDA-2001-N-0178", "Tab B Changes of Initial Draft (FRN 70FR33998) Submitted to OMB OIRA for Review and Action re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:26:14Z", null, 0, 0, "09000064804e1634"], ["FDA-2001-N-0178-0030", "FDA", "FDA-2001-N-0178", "Reference 33 FDA CDRH November 15, 2000 Assessment of the Impact of the Proposed Amendments to the Diagnostic X-ray Equipment Performance Standard Addressing Fluoroscopic X-ray Systems re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:19:54Z", null, 0, 0, "09000064804e15cd"], ["FDA-2001-N-0178-0022", "FDA", "FDA-2001-N-0178", "Reference 21 Rosenstein, M. et al., DHHS FDA Handbook of Selected Tissue Doses for the Upper Gastrointestinal Fluoroscopic Examination re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:10:35Z", null, 0, 0, "09000064804e15be"], ["FDA-2001-N-0178-0035", "FDA", "FDA-2001-N-0178", "Tab A Initial Draft (FRN 70FR33998) Submitted to OMB OIRA for Review re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:25:47Z", null, 0, 0, "09000064804e163b"], ["FDA-2001-N-0178-0032", "FDA", "FDA-2001-N-0178", "Tab A Initial Draft (FRN) Submitted to OMB OIRA for Review re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-02T05:00:00Z", 2016, 2, null, null, "2016-02-02T17:23:06Z", null, 0, 0, "09000064804e15e4"], ["FDA-2001-N-0178-0010", "FDA", "FDA-2001-N-0178", "List of References re: Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2016-02-01T05:00:00Z", 2016, 2, null, null, "2016-02-01T17:13:23Z", null, 0, 0, "09000064804e15d8"], ["FDA-2001-N-0178-0009", "FDA", "FDA-2001-N-0178", "Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components; Correction", "Proposed Rule", "Correction", "2015-03-17T04:00:00Z", 2015, 3, null, null, "2016-02-01T17:10:32Z", null, 0, 0, "09000064804e1595"], ["FDA-2001-N-0178-0008", "FDA", "FDA-2001-N-0178", "Letter from FDA CDRH to GE OEC Medical Systems, Inc.", "Other", "Letter(s)", "2006-05-08T04:00:00Z", 2006, 5, null, null, "2016-02-02T17:47:04Z", null, 0, 0, "09000064804e164b"], ["FDA-2001-N-0178-0007", "FDA", "FDA-2001-N-0178", "Letter from FDA CDRH to GE Heathcare", "Other", "Letter(s)", "2006-05-08T04:00:00Z", 2006, 5, null, null, "2016-02-02T17:43:54Z", null, 0, 0, "09000064804e1648"], ["FDA-2001-N-0178-0006", "FDA", "FDA-2001-N-0178", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Notice", "Notice of Approval", "2005-06-30T04:00:00Z", 2005, 6, "2005-06-29T04:00:00Z", "2007-01-01T04:59:59Z", "2016-02-02T17:35:36Z", null, 0, 0, "09000064804e1632"], ["FDA-2001-N-0178-0005", "FDA", "FDA-2001-N-0178", "Cover Sheet for Supporting Statement", "Supporting & Related Material", "Background Material", "2005-06-30T04:00:00Z", 2005, 6, null, null, "2016-02-03T16:20:48Z", null, 0, 0, "09000064804e162f"], ["FDA-2001-N-0178-0004", "FDA", "FDA-2001-N-0178", "Supporting Statement for Performance Standard for Diagnostic X-RAY Systems and Their Major Components", "Supporting & Related Material", "Background Material", "2005-06-30T04:00:00Z", 2005, 6, null, null, "2016-02-03T16:16:57Z", null, 0, 0, "09000064804e162d"], ["FDA-2001-N-0178-0003", "FDA", "FDA-2001-N-0178", "Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components Pages 101 through 170", "Rule", "Notice of Final Rule", "2005-06-21T04:00:00Z", 2005, 6, "2005-06-09T04:00:00Z", null, "2016-02-02T17:30:52Z", "70FR33998", 0, 0, "09000064804e1628"], ["FDA-2001-N-0178-0002", "FDA", "FDA-2001-N-0178", "Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components Pages 1 through 100", "Rule", "Notice of Final Rule", "2005-06-21T04:00:00Z", 2005, 6, "2005-06-09T04:00:00Z", null, "2016-02-02T17:29:43Z", null, 0, 0, "09000064804e1623"], ["FDA-2001-N-0178-0001", "FDA", "FDA-2001-N-0178", "Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2002-12-10T05:00:00Z", 2002, 12, "2002-12-10T05:00:00Z", "2003-04-10T03:59:59Z", "2016-02-03T22:01:16Z", null, 0, 0, "09000064804e1548"]], "truncated": false, "filtered_table_rows_count": 41, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2001-N-0178"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178", "results": [{"value": "FDA", "label": "FDA", "count": 41, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-N-0178", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 32, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&document_type=Rule", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178", "results": [{"value": 2016, "label": 2016, "count": 30, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&posted_year=2016", "selected": false}, {"value": 2005, "label": 2005, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&posted_year=2005", "selected": false}, {"value": 2006, "label": 2006, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&posted_year=2006", "selected": false}, {"value": 2023, "label": 2023, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&posted_year=2023", "selected": false}, {"value": 2002, "label": 2002, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&posted_year=2002", "selected": false}, {"value": 2015, "label": 2015, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&posted_year=2015", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2001-N-0178&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 422.0352179836482, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}